Table 2.
Disease category | Age/sex | Recurrent infections | IgG levels (g/l) | IgM levels (g/l) | IgA levels (g/l) | Vaccine responses | CD19 cells (%) | CD4/ CD8 ratio | CD16/ CD56 cells (%) | Neutrophil chemotaxis | Reference |
---|---|---|---|---|---|---|---|---|---|---|---|
‘Possible’ CVID | 7/M | Bacterial + viral | 7·0* | 0·3 | 0·8 | Absent/†† | 24 | 2·2‡ | 1·0§ | Abnormal | [4] |
18/M | Bacterial + viral | 4·8§ | 0·3 | 0·7 | Normal/†† | 1·2§ | 0·5§ | 1·8§ | – | [4] | |
41/F | Bacterial | 5·8§ (6·3–12·9 g/l) | – | – | Absent (pneumococcal) | – | Normal | – | – | [5] | |
59/M | Bacterial | 1·3§ | < 0·2§ | < 0·2§ | – | 1·10§ | 1·4§ | 1·43§ | – | Index case | |
Hypogamma- globulinaemia of other types | 4 month/F 1·5/M | Bacterial Bacterial | 3·8§ (6·0–15·75 g/l) 6·8 | 0·40§ (0·7–2·3 g/l) <0·1§ | 0·07§ (0·2–1·4 g/l) 0·3 | Absent – | CD20–6 (10–30%) – | 2·0 – | 3 – | Abnormal – | [6] [7] |
2/M | Bacterial + viral | 6·1§,¶ | 0·3 | 0·2§ | – | – | – | – | – | [4] | |
– | Bacterial | – | Low | – | – | Normal | Normal | – | Abnormal | [8] | |
– | Bacterial | – | – | Low | – | Normal | Low | – | Abnormal | [8] | |
– | Bacterial | – | – | Low | – | Normal | Normal | – | Abnormal | [8] | |
– | Bacterial | – | Low | – | – | Normal | Normal | – | Abnormal | [8] | |
16/M | Bacterial | 0·36§ | 0·03§ | 0·12§ | – | – | – | – | – | [9] | |
3/M | Nil | 4·8§ | 0·07§ | Absent§ | – | – | – | – | – | [10] | |
6·5/F | Nil | 3·8§ | 0·78 | 0·18§ | – | – | – | – | – | [10] | |
Other immunological abnormalities | 8/M | Bacterial + viral | 9·8 | 0·3 | 0·7 | –/†† | 9·3 | 2·3 | 1·5§ | Abnormal | [4] |
17/M | Bacterial | 8·2 | 0·4 | 11·1 | – | – | –‡ | – | Abnormal | [4] | |
14/F | Bacterial | 16·5 | 1·3 | 2·7 | Normal/†† | 15 | 1·0§ | 3·5§ | – | [4] |
Low IgG1 levels;
Low anti-B isohaemagglutinin levels;
low lymphocyte proliferation to concanavalin A/pokeweed mitogen;
low for age;
low IgG1 and IgG3 levels; –, not studied/available.